Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 230

Results For "Development"

3676 News Found

CPHI & PMEC India 2022 showcases array of machinery, ingredients and technology
Drug Approval | November 30, 2022

CPHI & PMEC India 2022 showcases array of machinery, ingredients and technology

South Asia’s largest exhibition for pharma brought together over 50,000 visitors from across the globe


Gland Pharma to buy French pharma company Cenexi
News | November 30, 2022

Gland Pharma to buy French pharma company Cenexi

Gland Pharma enters into a Put Option Agreement to acquire 100% of Cenexi Group


Azelis inaugurates pharmaceuticals & healthcare lab for APAC in India
News | November 28, 2022

Azelis inaugurates pharmaceuticals & healthcare lab for APAC in India

The pharma laboratory is fully equipped with all the machinery needed to support formulation development, resolve technical challenges, and provide customer demonstrations


Sai Life Sciences appoints Stephen Hermitage as VP, CMC
People | November 28, 2022

Sai Life Sciences appoints Stephen Hermitage as VP, CMC

Steve joins Sai Life Sciences from GlaxoSmithKline (GSK) where he was a department head and member of the global chemical development leadership team.


Chantal van Gils joins NDA Advisory Board as Director of Epidemiology
People | November 27, 2022

Chantal van Gils joins NDA Advisory Board as Director of Epidemiology

She will provide strategic advice and scientific leadership to support clients in clinical development, registration strategy, submission, early post-approval strategy


Delivery solution provider ZIM Laboratories Limited lists on NSE
News | November 26, 2022

Delivery solution provider ZIM Laboratories Limited lists on NSE

The total quantity traded at NSE stood at 34,653 shares and the total turnover stood at Rs. 117.23 lakh.


AstraZeneca receives import and market permission from CDSCO for Dapagliflozin
Drug Approval | November 26, 2022

AstraZeneca receives import and market permission from CDSCO for Dapagliflozin

The receipt of this permission paves way for the launch of Dapagliflozin (Forxiga) tablets of 10 mg in India for the specified additional/expanded indication, subject to the receipt of related statutory approvals


Ministry of Ayush and DST sign MoU to identify areas of research
News | November 26, 2022

Ministry of Ayush and DST sign MoU to identify areas of research

The two have agreed to jointly undertake R&D activities on scientific validation of Ayush concepts, procedures and products


India’s plan for containment of AMR focuses on an integrated One Health approach: Dr. Bharti
News | November 26, 2022

India’s plan for containment of AMR focuses on an integrated One Health approach: Dr. Bharti

It serves to leverage the strengths of various institutions to coordinate AMR surveillance lab networks


USFDA inspects Lupin's Mandideep Unit-1 facility
News | November 25, 2022

USFDA inspects Lupin's Mandideep Unit-1 facility

The inspection of the facility resulted in issuance of a Form-483 with eight observations each for the Drug Product facility and API facility at the site